Margaret Kempen - Core Laboratories Director

CLB Stock  USD 15.33  0.07  0.45%   

Director

Ms. Margaret Ann van Kempen has served as Independent Member of the Board of Supervisory Directors of Core Laboratories N.V. since May 16, 2012. She is Member of the Compensation Committee and the Nominating, Governance and Corporationrationrate Responsibility Committee at the Company. Ms. van Kempen was the owner and managing partner of Van Kempen Public Relations Public Affairs since 1997. She has experience in strategic corporate communications and investor relations, with a focus on reputation and risk management. She has provided litigation PR and communications advice on a wide variety of issues in high profile cases in and outside The Netherlands. Her clients cover a range of sectors including telecommunications, energy, information technology, professional services and fashion. From 1988 to 1995 she was Director European Affairs of Financial Times Television. Before that she worked in government and semigovernment organizations including the Ministry of Economic Affairs. since 2012.
Age 67
Tenure 13 years
Phone713 328 2673
Webhttps://www.corelab.com

Core Laboratories Management Efficiency

The company has Return on Asset of 0.0553 % which means that on every $100 spent on assets, it made $0.0553 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1319 %, implying that it generated $0.1319 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.
Core Laboratories NV has 180.14 M in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Core to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Pamela RollinsRPC Inc
63
Darrell HollekOil States International
64
Brian SmallCactus Inc
61
Terry BonnoNow Inc
62
Patrick GunningRPC Inc
61
Susan BellRPC Inc
58
William KleefOil States International
68
William BerryOceaneering International
68
Michael SheenGeospace Technologies
76
Thomas StanNorth American Construction
62
Deanna GoodwinOceaneering International
55
Alan SempleCactus Inc
60
Amy KreislerRPC Inc
51
James CrandellNow Inc
66
Cornelis LinseMRC Global
71
Bryan PinneyNorth American Construction
67
Steven WebsterOceaneering International
69
Sonya ReedNow Inc
47
Hallie VanderhiderOil States International
63
James WilliamsRPC Inc
85
Henry TippieRPC Inc
92
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in 6316 Windfern Road, Houston, TX, United States, 77040 and employs 3,500 people. Core Laboratories is listed under Oil & Gas Equipment & Services category by Fama And French industry classification.

Management Performance

Core Laboratories Leadership Team

Elected by the shareholders, the Core Laboratories' board of directors comprises two types of representatives: Core Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Core. The board's role is to monitor Core Laboratories' management team and ensure that shareholders' interests are well served. Core Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Core Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
Gwendolyn MBA, Senior Relations
J Dumas, Vice President Business Development
Martha Carnes, Presiding Non-Executive Lead Independent Member of the Supervisory Board
Lawrence Bruno, Chairman of the Supervisory Board, President, Chief Executive Officer, Chief Operating Officer
Monique Eeuwijk, Non-Executive Independent Member of the Supervisory Board
Kevin Daniels, Vice President, Chief Accounting Officer
Jacobus Schouten, Managing Director
Christopher Hill, Chief Financial Officer, Senior Vice President
Kwaku Temeng, Non-Executive Independent Member of the Supervisory Board
Sow Teo, Treasurer VP
Gregory Barnett, Non-Executive Independent Member of the Supervisory Board
Margaret Kempen, Independent Member of the Board of Supervisory Directors
Mark Tattoli, Senior Vice President General Counsel, Secretary
Mark Elvig, Senior Vice President, Secretary, and General Counsel
Harvey Klingensmith, Non-Executive Independent Member of the Supervisory Board
Michael Straughen, Non-Executive Independent Member of the Supervisory Board
Gwendolyn Gresham, Senior Vice President Corporate Development and Investor Relations
Leslie Linklater, Organization, People
Billy Anthony, President Tools

Core Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Core Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.